"Formularies as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about lists of drugs or collections of recipes, formulas, and prescriptions for the compounding of medicinal preparations. Formularies differ from PHARMACOPOEIAS in that they are less complete, lacking full descriptions of the drugs, their formulations, analytic composition, chemical properties, etc. In hospitals, formularies list all drugs commonly stocked in the hospital pharmacy.
| Descriptor ID |
D005569
|
| MeSH Number(s) |
L01.178.682.192.836.535
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Formularies as Topic".
Below are MeSH descriptors whose meaning is more specific than "Formularies as Topic".
This graph shows the total number of publications written about "Formularies as Topic" by people in this website by year, and whether "Formularies as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Formularies as Topic" by people in Profiles.
-
Sacchetti A, Pagliaro AM, Boyle MJ. An emergency department eye formulary. Am J Emerg Med. 2024 09; 83:142-143.
-
Karel LI, Delisle DR, Anagnostis EA, Wordell CJ. Implementation of a formulary management process. Am J Health Syst Pharm. 2017 Aug 15; 74(16):1245-1252.
-
Bielory L. United States pharmacopeia development of the Medicare model formulary guidelines. Am J Geriatr Cardiol. 2005 Nov-Dec; 14(6):301-7.
-
Strain JJ, Chiu NM, Sultana K, Karim A, Caliendo G, Mustafa S, Strain JJ. Psychotropic drug versus psychotropic drug-update. Gen Hosp Psychiatry. 2004 Mar-Apr; 26(2):87-105.
-
Schrogie JJ. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Health system perspective regarding glycoprotein IIb/IIIa inhibitor therapy. Am Heart J. 1999 May; 137(5):S126-8.
-
Anderson ML, Barrett CW, Kopelman PG. Interpretation and management of PACT (prescribing analysis and cost) data on formularies. BMJ. 1990 Sep 08; 301(6750):492.